APA (7th ed.) Citation

Tsai, T., Su, P., Huang, S., Kuo, M., Lin, C., Wu, C., . . . Su, Y. (2023). The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-11398-w

Chicago Style (17th ed.) Citation

Tsai, Tsung-Han, et al. "The Prognostic Significance of Histologic Variant on Survival Outcomes in Patients with Metastatic Urothelial Carcinoma Receiving Immune Checkpoint Inhibitor Therapy." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-11398-w.

MLA (9th ed.) Citation

Tsai, Tsung-Han, et al. "The Prognostic Significance of Histologic Variant on Survival Outcomes in Patients with Metastatic Urothelial Carcinoma Receiving Immune Checkpoint Inhibitor Therapy." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-11398-w.